Awaiting development: Guidance and quality standards

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Area of interest

Area of interest

Type

Type

Guidance programme 1 selected

Guidance programme

Showing 301 to 303 of 303

TitleType
Zolbetuximab with nab-paclitaxel and gemcitabine for untreated claudin 18.2-positive metastatic pancreatic cancer [ID6444]Technology appraisal guidance
Zolbetuximab with nab-paclitaxel and gemcitabine for untreated claudin 18.2-positive metastatic pancreatic cancer [TSID12040]Technology appraisal guidance
Zongertinib for untreated HER2-positive unresectable advanced non-small-cell lung cancer [TSID12179]Technology appraisal guidance

Results per page

  1. 10
  2. 25
  3. 50
  4. All